Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Adenoviruses News

Home | Index > Health > A-Z Index > Adenoviruses

TAKE THIS POLL
Regardless of your general preferences, which U.S. presidential candidate's Iraq policy do you support? (Jul. 15, 2008) John McCain's policy. Barack Obama's 's policy. Don't know.

NIAID Suspends the Pave 100 HIV Vaccine Trial 18 Jul 2008 18:14 GMT
... to be among males who were both uncircumcised and had pre-existing neutralizing antibodies to adenovirus type 5 (Ad5), the common cold virus used in the vaccine as a carrier ...
Science & Medicine - NIAID Director Fauci Cancels Planned HIV Vaccine Tria 18 Jul 2008 15:37 GMT
... that both stimulate CD4+ T cells against HIV and both contain the cold virus adenovirus-5 ( , 3/25). The VRC candidate also contained pieces of HIV strains from around ...
U.S. cancels large trial of AIDS vaccine 18 Jul 2008 14:00 GMT
... testing. The vaccine was made from a weakened version of a common cold virus, adenovirus type 5, which served as a way to deliver three synthetically produced genes from ...
Large HIV vaccine study will not go ahead 18 Jul 2008 13:57 GMT
... raised concerns about the use of an adenoviral vector (the carrier for the HIV gene ... uncircumcised and had pre-existing neutralising antibodies to adenovirus type 5 (Ad5) had the highest risk of ...
Galapagos announces first milestone in osteoporosis ... 18 Jul 2008 13:00 GMT
... MECHELEM, Belgium - Galapagos NV announced today that it ... of pre-clinical candidates. BioFocus DPI also provides adenoviral reagents for rapid identification and validation of ...

--> Galapagos announces first milestone in osteoporosis collaboration with Lilly 18 Jul 2008 06:59 GMT
... Galapagos announces first milestone in osteoporosis collaboration with Lilly ... of pre-clinical candidates. BioFocus DPI also provides adenoviral reagents for rapid identification and validation of ...
Galapagos announces first milestone in osteoporosis collaboration with Lilly 18 Jul 2008 06:54 GMT
... Galapagos announces first milestone in osteoporosis collaboration with Lilly ... of pre-clinical candidates. BioFocus DPI also provides adenoviral reagents for rapid identification and validation of ...
JCI online early table of contents: July 17, 2008 18 Jul 2008 04:40 GMT
... for the development of therapeutics for genetic and acquired heart diseases. TITLE: Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart AUTHOR ...
Human trial for vaccine against HIV is canceled 18 Jul 2008 03:08 GMT
... testing. The vaccine was made from a weakened version of a common cold virus, adenovirus type 5, which served as a way to deliver three synthetically produced genes — ...
Trial for Vaccine Against H.I.V. Is Canceled 18 Jul 2008 02:11 GMT
... in human testing. The vaccine was made from a weakened version of a virus, adenovirus type 5, which served as a way to deliver three synthetically produced genes — ...

Not satisfied with this news section? Make your own with the Newsletter Manager or try our other media monitoring services.

Human Trial of AIDS Vaccine Canceled 18 Jul 2008 01:08 GMT
... for the Vaccine Research Center where it was developed, contain a cold virus called adenovirus-5. Because of that similarity to the Merck vaccine, the VRC shot probably wouldn't have ...
Human Trial for Vaccine Against H.I.V. Is Canceled 18 Jul 2008 00:58 GMT
... in human testing. The vaccine was made from a weakened version of a virus, adenovirus type 5, which served as a way to deliver three synthetically produced genes — ...
Plans for human trial of AIDS vaccine are canceled 17 Jul 2008 23:31 GMT
... testing. The vaccine was made from a weakened version of a common cold virus, adenovirus type 5, which served as a way to deliver three synthetically produced genes from ...
HIV Vaccine Trial Cancelled by NIH 17 Jul 2008 22:25 GMT
... to be among males who were both uncircumcised and had pre-existing neutralizing antibodies to adenovirus type 5 (Ad5), the common cold virus used in the vaccine as a carrier ...
Statement: NIAID Will Not Move Forward with the Pave 100 HIV Vaccine Trial VRC 17 Jul 2008 21:54 GMT
... to be among males who were both uncircumcised and had pre-existing neutralizing antibodies to adenovirus type 5 (Ad5), the common cold virus used in the vaccine as a carrier ...
U.S. drops trial of one AIDS vaccine 17 Jul 2008 21:33 GMT
... and who were not circumcised. The vaccine used a common virus known as an adenovirus to carry bits of the AIDS virus. "It didn't work, it wasn't beneficial and ...
Trial of one AIDS vaccine dropped 17 Jul 2008 21:33 GMT
... and who were not circumcised. The vaccine used a common virus known as an adenovirus to carry bits of the AIDS virus. "It didn't work, it wasn't beneficial and ...
Plans for human trial of AIDS vaccine is canceled 17 Jul 2008 20:36 GMT
... testing. The vaccine was made from a weakened version of a common cold virus, adenovirus type 5, which served as a way to deliver three synthetically produced genes from ...
Plans for Human Trial of H.I.V. Vaccine Canceled 17 Jul 2008 19:00 GMT
... in human testing. The vaccine was made from a weakened version of a virus, adenovirus type 5, which served as a way to deliver three synthetically produced genes from ...
NIAID will not move forward with the PAVE 100 HIV Vaccine Trial 17 Jul 2008 15:36 GMT
... to be among males who were both uncircumcised and had pre-existing neutralizing antibodies to adenovirus type 5 (Ad5), the common cold virus used in the vaccine as a carrier ...

THESE STORIES ARE NOT PUBLISHED BY IPD GROUP, INC. AND THESE LINKS WILL TAKE YOU TO OTHER WEBSITES. SOME OF THESE WEBSITES REQUIRE THEIR OWN REGISTRATION TO READ THEIR STORIES. PLEASE READ THE DISCLAIMER FOR MORE DETAILS. >>>

Boehringer Ingelheim licenses drug targets from auto... 17 Jul 2008 12:57 GMT
... MECHELEN, Belgium - Galapagos NV (Euronext: GLPG) announced today ... of pre-clinical candidates.� BioFocus DPI also provides adenoviral reagents for rapid identification and validation of ...
--> Boehringer Ingelheim licenses drug targets from autoimmune collaboration with Galapagos 17 Jul 2008 06:30 GMT
... Boehringer Ingelheim licenses drug targets from autoimmune collaboration with ... of pre-clinical candidates. BioFocus DPI also provides adenoviral reagents for rapid identification and validation of ...
Boehringer Ingelheim licenses drug targets from autoimmune collaboration with Galapagos 17 Jul 2008 06:27 GMT
... MECHELEN, BELGIUM -- (MARKET WIRE) -- 07/17/08 -- Mechelen, ... of pre-clinical candidates. BioFocus DPI also provides adenoviral reagents for rapid identification and validation of ...
GM's shot in the arm for medicine 16 Jul 2008 11:54 GMT
... Certain agricultural applications of gene modification are well known, ... the naturally-occurring p53 tumour suppressor with a adenoviral delivery system to kill cancer cells and ...
NanoViricide's EKC Eye Drug Candidate Stopped Clinical Conjunctivitis Pathology 16 Jul 2008 11:50 GMT
... NanoViricides, Inc. (OTC BB: NNVC.OB) reported that excellent ... regarding potential licensing of a nanoviricide against adenoviral EKC. The two clinical scores employed were ...